The story of Viagra and the medicinal industry presents a challenging picture for careful investors. Initially, copyright's blockbuster drug transformed the treatment of erectile dysfunction, producing significant profits and influencing the current pharmaceutical landscape. However, exclusive rights expiration and the rise of alternative versions